Table 2 Bivariate analysis of factors related to severe COVID-19 infection
Variable | Severe-critical | Asymptomatic to moderate | RR (95%CI) | P |
|---|---|---|---|---|
Gender [n (%)] | ||||
Male | 17 (73.9) | 242 (75.9) | 0.91 (0.37 − 2.23) | 1.000 |
Female | 6 (26.1) | 77 (24.1) | ||
Age [n (%)] | ||||
≥ 50 years | 4 (17.4) | 38 (11.9) | 1.50 (0.54 − 4.21) | 0.505 |
< 50 years | 19 (82.6) | 281 (88.1) | ||
BMI [n (%)] | ||||
Obese (≥ 30) | 4 (17.4) | 23 (7.2) | 2.46 (0.90 − 6.70) | 0.096 |
Non-obese (< 30) | 19 (82.6) | 296 (92.8) | ||
Antiretroviral status [n (%)] | ||||
Not-using ART | 7 (30.4) | 15 (4.7) | 6.36 (2.93 − 13.83) | < 0.001 |
On ART | 16 (69.6) | 304 (95.3) | ||
Recent absolute CD4 [n (%)] | ||||
< 200 | 11 (47.8) | 37 (11.6) | 5.62 (2.63 − 12.00) | < 0.001 |
≥ 200 | 12 (52.2) | 282 (88.4) | ||
Opportunistic infection [n (%)] | ||||
Active OI | 9 (39.1) | 25 (7.8) | 5.82 (2.73 − 12.44) | < 0.001 |
No active OI | 14 (60.9) | 294 (92.2) | ||
Any comorbidity* [n (%)] | ||||
Yes | 11 (47.8) | 53 (16.6) | 3.98 (1.84 − 8.61) | 0.001 |
No | 12 (52.2) | 266 (83.4) | ||